Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LORI H TRAVIS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1093794885
CMS profile
276843
Location
PHOENIX, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$51,454.40

292 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 4 of 6; records 151–200 of 292 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LORI H TRAVIS

NPI 1093794885 · CMS profile ID 276843

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

PHOENIX, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 6; records 151–200 of 292 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1093794885?year=2022&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LORI H TRAVIS, NPI 1093794885, CMS profile ID 276843. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 6; records 151–200 of 292 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1093794885?year=2022&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). LORI H TRAVIS, NPI 1093794885, CMS profile ID 276843. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 6; records 151–200 of 292 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1093794885?year=2022&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
LORI H TRAVIS, NPI 1093794885, CMS profile ID 276843, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 6; records 151–200 of 292 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1093794885?year=2022&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

292 matching records · $51,454.40 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 292 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 292.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Janssen Pharmaceuticals, Inc $12.1707/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885706383 CMS
ABBVIE INC. $13.8007/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892548449 CMS
Biogen, Inc. $22.5707/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923449407 CMS
Novartis Pharmaceuticals Corporation $18.3407/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894422809 CMS
Amgen Inc. $16.8107/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939190179 CMS
Mallinckrodt Hospital Products Inc. $1,715.0007/12/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937529859 CMS
ABBVIE INC. $26.5006/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892548447 CMS
Biogen, Inc. $49.9806/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923399935 CMS
Biogen, Inc. $2,646.0006/29/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923415909 CMS
Mallinckrodt Hospital Products Inc. $2,575.0006/28/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937529857 CMS
Acorda Therapeutics, Inc $15.5706/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920335687 CMS
Banner Life Sciences, LLC $10.6606/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957720521 CMS
GENZYME CORPORATION $3.4006/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938872997 CMS
Janssen Pharmaceuticals, Inc $16.8006/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885706419 CMS
Mallinckrodt Hospital Products Inc. $20.7006/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937529855 CMS
Amgen Inc. $18.4306/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939190177 CMS
Celgene Corporation $43.5906/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932601935 CMS
ABBVIE INC. $9.0706/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892548445 CMS
Banner Life Sciences, LLC $13.7806/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957720369 CMS
Banner Life Sciences, LLC $3.4006/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957720371 CMS
Biogen, Inc. $108.7406/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923401255 CMS
Teva Pharmaceuticals USA, Inc. $22.4306/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954683849 CMS
ABBVIE INC. $11.1606/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892548443 CMS
Mallinckrodt Hospital Products Inc. $7.0906/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937529853 CMS
Novartis Pharmaceuticals Corporation $19.9006/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894422833 CMS
Acorda Therapeutics, Inc $3.0406/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920335691 CMS
Amgen Inc. $13.8306/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939190167 CMS
Banner Life Sciences, LLC $19.2006/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957719939 CMS
Banner Life Sciences, LLC $1.0106/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957719941 CMS
Banner Life Sciences, LLC $17.7206/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957719917 CMS
Lilly USA, LLC $14.2305/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918171583 CMS
Biohaven Pharmaceutical Holding Company Ltd. $12.6505/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923756911 CMS
Acorda Therapeutics, Inc $19.0905/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920335689 CMS
ABBVIE INC. $9.8205/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892548441 CMS
Janssen Pharmaceuticals, Inc $18.2905/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885706401 CMS
GENZYME CORPORATION $6.2105/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938873009 CMS
Horizon Therapeutics plc $37.4305/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937706279 CMS
ABBVIE INC. $9.3005/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892548439 CMS
Mallinckrodt Hospital Products Inc. $14.1505/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937529849 CMS
Mallinckrodt Hospital Products Inc. $9.9605/19/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937529851 CMS
Teva Pharmaceuticals USA, Inc. $27.6005/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954683669 CMS
ABBVIE INC. $18.1205/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892548437 CMS
Amgen Inc. $24.8105/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939190165 CMS
GENZYME CORPORATION $4,000.0005/16/2022 Grant No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938872999 CMS
Banner Life Sciences, LLC $11.8105/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957719457 CMS
Banner Life Sciences, LLC $0.7805/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957719459 CMS
GENZYME CORPORATION $29.2705/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938872987 CMS
Novartis Pharmaceuticals Corporation $20.5105/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894422831 CMS
Banner Life Sciences, LLC $0.7605/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957719407 CMS
Banner Life Sciences, LLC $16.3305/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 957719409 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $157,011.41 174
PY2020 $49,159.95 100
PY2021 $57,757.69 248
PY2022 $51,454.40 292
PY2023 $18,043.97 245
PY2024 $40,882.71 279
PY2025 $31,203.58 255

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $82,186.65 12
PY2024 Principal investigator $151,827.45 16
PY2023 Principal investigator $180,293.02 64
PY2022 Principal investigator $557,973.54 22
PY2021 Principal investigator $112,269.30 11
PY2020 Recipient $1,009.93 2
PY2020 Principal investigator $8,594.80 6
PY2019 Principal investigator $750.00 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 GENZYME CORPORATION $4,038.60 11/17/2025 Non-covered Recipient Entity
Perseverance Research Center
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226148780
Principal investigator 1 GENZYME CORPORATION $4,038.60 09/29/2025 Non-covered Recipient Entity
Perseverance Research Center
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226148776
Principal investigator 1 GENZYME CORPORATION $5,098.00 08/11/2025 Non-covered Recipient Entity
Perseverance Research Center
A Randomized, Double-blind, Phase 3 Study Comparing Efficacy and Safety of Frexalimab (SAR441344) to Placebo in Adult Participants With Nonrelapsing Secondary Progressive Multiple Sclerosis No dispute reported 06/30/2026 1226148772
Principal investigator 1 GENZYME CORPORATION $5,156.08 08/04/2025 Non-covered Recipient Entity
Perseverance Research Center
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226148762
Principal investigator 1 GENZYME CORPORATION $7,175.38 08/04/2025 Non-covered Recipient Entity
Perseverance Research Center
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226148765
Principal investigator 1 GENZYME CORPORATION $3,500.00 08/04/2025 Non-covered Recipient Entity
Perseverance Research Center
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226148768
Principal investigator 1 GENZYME CORPORATION $6,057.90 07/02/2025 Non-covered Recipient Entity
Perseverance Research Center
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226148871
Principal investigator 1 GENZYME CORPORATION $12,610.20 05/19/2025 Non-covered Recipient Entity
Perseverance Research Center
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226148844
Principal investigator 1 GENZYME CORPORATION $1,650.00 04/21/2025 Non-covered Recipient Entity
Perseverance Research Center
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226148821
Principal investigator 1 GENZYME CORPORATION $23,000.00 03/17/2025 Non-covered Recipient Entity
Perseverance Research Center
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226148796
Principal investigator 1 GENZYME CORPORATION $6,500.00 02/18/2025 Non-covered Recipient Entity
Perseverance Research Center
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226148790
Principal investigator 1 GENZYME CORPORATION $3,361.89 01/27/2025 Non-covered Recipient Entity
Perseverance Research Center
Master Protocol of Two Independent, Randomized, Double-blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis No dispute reported 06/30/2026 1226148801